Literature DB >> 12412709

High-frequency percussive ventilation as a salvage modality in adult respiratory distress syndrome: a preliminary study.

Stephen M Paulsen1, Garry W Killyon, David J Barillo.   

Abstract

Despite multiple advances in critical care patients with severe adult respiratory distress syndrome (ARDS) can exhaust the capability of conventional ventilation; this results in respiratory failure and death. High-frequency percussive ventilation (HFPV), which was initially utilized for salvage of burn patients with smoke inhalation injury refractory to conventional ventilation, has evolved as a standard of burn care. Based on our experience with HFPV in burn patients the burn team was consulted to provide salvage ventilation for non-burn surgical intensive care unit patients with refractory respiratory failure. Over a 14-month period ten patients with refractory ARDS from multiple causes were treated. Retrospective chart review was performed. Respiratory parameters were assessed before and 24 hours after initiation of HFPV. Mean values of fraction of inspired oxygen (FiO2), pH, partial pressure of O2 in arterial blood (PaO2), partial pressure of CO2 in arterial blood (PaCO2), HCO3, oxygen saturation in arterial blood (SaO2), PaO2/FiO2, and peak inspiratory pressure were compared. Significant improvement in oxygenation was reflected by increases in SaO2, PaO2, and the PaO2/FiO2 ratio in the first 24 hours of HFPV. No significant increase in peak inspiratory pressure was documented by conversion from conventional ventilation to HFPV. No hemodynamic changes directly associated with HFPV were noted. Seven of ten patients failing conventional ventilation survived to hospital discharge after salvage therapy with HFPV. We advocate further studies of HFPV in non-burn patients with ARDS both as salvage therapy and as replacement for conventional ventilation for the initial treatment for ARDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412709

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Gas distribution in a two-compartment model ventilated in high-frequency percussive and pressure-controlled modes.

Authors:  Umberto Lucangelo; Agostino Accardo; Alessandro Bernardi; Massimo Ferluga; Massimo Borelli; Vittorio Antonaglia; Fabio Riscica; Walter A Zin
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

2.  Intrapulmonary percussive ventilation in tracheostomized patients: a randomized controlled trial.

Authors:  Enrico M Clini; Francesca Degli Antoni; Michele Vitacca; Ernesto Crisafulli; Mara Paneroni; Sheila Chezzi-Silva; Maurizio Moretti; Ludovico Trianni; Leonardo M Fabbri
Journal:  Intensive Care Med       Date:  2006-10-24       Impact factor: 17.440

3.  Suspected Case of Drug-Induced Acute Respiratory Distress Syndrome following Trimethoprim-Sulfamethoxazole Treatment.

Authors:  Julia Natterer; Frida Rizzati; Marie-Hélène Perez; David Longchamp; Vivianne Amiet; Quentin DeHalleux; Kim Dao; Thomas Ferry
Journal:  J Pediatr Intensive Care       Date:  2020-07-30

4.  High-frequency percussive ventilation attenuates lung injury in a rabbit model of gastric juice aspiration.

Authors:  Jérôme Allardet-Servent; Fabienne Bregeon; Stéphane Delpierre; Jean-Guillaume Steinberg; Marie-José Payan; Sylvie Ravailhe; Laurent Papazian
Journal:  Intensive Care Med       Date:  2007-09-21       Impact factor: 17.440

5.  High frequency percussive ventilation in pediatric acute respiratory failure.

Authors:  Andrew D Butler; Cheryl L Dominick; Nadir Yehya
Journal:  Pediatr Pulmonol       Date:  2020-12-08

6.  ICU cornerstone: high frequency ventilation is here to stay.

Authors:  Peter C Rimensberger
Journal:  Crit Care       Date:  2003-07-02       Impact factor: 9.097

7.  High-frequency percussive ventilation in severe acute respiratory distress syndrome: A single center experience.

Authors:  Herbert Spapen; Marianne Borremans; Marc Diltoer; Viola Van Gorp; Duc Nam Nguyen; Patrick M Honoré
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.